Notably, Kim et al. provided compelling evidence that pharmacological modulation of TMBIM6-mediated Ca2+ leakage effectively suppresses both tumorigenesis and cancer progression, thereby establishing a novel therapeutic paradigm for malignant tumor treatment [22]. This evidence concerns the gene TMBIM6 and cancer.